A detailed history of Entropy Technologies, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Entropy Technologies, LP holds 8,141 shares of LLY stock, worth $6.55 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
8,141
Previous 3,812 113.56%
Holding current value
$6.55 Million
Previous $3.38 Billion 86.1%
% of portfolio
0.65%
Previous 0.35%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$727.2 - $932.06 $3.15 Million - $4.03 Million
4,329 Added 113.56%
8,141 $6.28 Billion
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $172,959 - $215,044
-224 Reduced 5.55%
3,812 $3.38 Billion
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $2.93 Million - $3.67 Million
4,036 New
4,036 $3.65 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $764B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Entropy Technologies, LP Portfolio

Follow Entropy Technologies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Entropy Technologies, LP with notifications on news.